Home
   Links
   Faculty Information
   Activities & Events
   Melanoma Care Centers
 
   Slide Library
   Polling Results
   Patient Resources
 
   Contact Us
   Register
   Log-in
   
 
 
 
 
 
 
 
 
 

Current Web/Pod Casts

Previous Web/Pod Casts

Update on Biomarkers of Melanoma and Their Relevance to Prognosis and Response to Therapy

Importance of Early Recognition and Management of Side Effects: Focusing on Emerging Therapies

Melanoma: Update on Emerging Therapies II

Revolution in Standard Treatments for Melanoma

Melanoma: Update on Emerging Therapies I

Chemotherapy of Melanoma

Management of Metastatic Melanoma: New Challenges Relative to Tumor Response to Targeted and Immunotherapy: Tumor Mutational Evolution and Eventual "Resistance" to Therapy

Advances in Immunotherapy for Metastatic Melanoma

The Management of In-Transit Melanoma

Current Status of Adjuvant Interferon-α (IFN-α) Therapy in Melanoma

The Role of Sentinel Lymph Node Biopsy (SLNB) in Prior Resected and Recurrent Melanoma

Immunotherapy of Melanoma Using Checkpoint Blockade

Melanoma Brain Metastases

AJCC Melanoma Staging 2009: Impact on Current Practices

Genomics and Proteomics in Melanoma Biomarker Development

Managing the Side Effects of Medical and Surgical Therapy To Keep the Patient on Therapy

Targeted Therapy in Melanoma: Recent Progress

Melanoma: A Mysterious Disease?

Scientific and Clinical Interpretation of New Data on IFN-a for Adjuvant Therapy of Melanoma

Signal Transduction Inhibitors in Melanoma: NOT One-Size-Fits-All

Update on histologic and molecular markers for melanoma

What's different about the 7th edition of the AJCC staging system?

SLNB: Decoding the controversies regarding its use and significance

Methods of biopsy; Mohs micrographic surgery vs standard resection for MIS; and the value of imiquimod

Managing adverse effects and improving patient compliance

Last Modified 02/02/2023